Specific Anti-SARS-CoV-2 Humoral and Cellular Immune Responses After Booster Dose of BNT162b2 Pfizer-BioNTech mRNA-Based Vaccine: Integrated Study of Adaptive Immune System Components

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), is modifying human activity all over the world with significant health and economic burden. The advent of the SARS-CoV-2 pandemic prompted the scientific community to learn the virus dynam...

Descripción completa

Detalles Bibliográficos
Autores principales: Busà, Rosalia, Sorrentino, Maria Concetta, Russelli, Giovanna, Amico, Giandomenico, Miceli, Vitale, Miele, Monica, Di Bella, Mariangela, Timoneri, Francesca, Gallo, Alessia, Zito, Giovanni, Di Carlo, Daniele, Conaldi, Pier Giulio, Bulati, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987231/
https://www.ncbi.nlm.nih.gov/pubmed/35401503
http://dx.doi.org/10.3389/fimmu.2022.856657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987231/
https://www.ncbi.nlm.nih.gov/pubmed/35401503
http://dx.doi.org/10.3389/fimmu.2022.856657

Ejemplares similares